ZA857057B - Pharmaceutical compositions containing diltiazem and alfuzosin - Google Patents

Pharmaceutical compositions containing diltiazem and alfuzosin

Info

Publication number
ZA857057B
ZA857057B ZA857057A ZA857057A ZA857057B ZA 857057 B ZA857057 B ZA 857057B ZA 857057 A ZA857057 A ZA 857057A ZA 857057 A ZA857057 A ZA 857057A ZA 857057 B ZA857057 B ZA 857057B
Authority
ZA
South Africa
Prior art keywords
alfuzosin
pharmaceutical compositions
compositions containing
containing diltiazem
diltiazem
Prior art date
Application number
ZA857057A
Other languages
English (en)
Inventor
Icilio Cavero
Peter Hicks
Salomon Langer
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of ZA857057B publication Critical patent/ZA857057B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
ZA857057A 1984-09-14 1985-09-13 Pharmaceutical compositions containing diltiazem and alfuzosin ZA857057B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8414088A FR2570275B1 (fr) 1984-09-14 1984-09-14 Compositions pharmaceutiques a base de diltiazem et d'alfusozine

Publications (1)

Publication Number Publication Date
ZA857057B true ZA857057B (en) 1986-06-25

Family

ID=9307716

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA857057A ZA857057B (en) 1984-09-14 1985-09-13 Pharmaceutical compositions containing diltiazem and alfuzosin

Country Status (11)

Country Link
EP (1) EP0178961B1 (de)
JP (1) JPS6172718A (de)
AU (1) AU574506B2 (de)
CA (1) CA1256031A (de)
DE (1) DE3579098D1 (de)
DK (1) DK160034C (de)
FR (1) FR2570275B1 (de)
HU (1) HU193448B (de)
IL (1) IL76377A (de)
NZ (1) NZ213465A (de)
ZA (1) ZA857057B (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2421888A1 (fr) * 1978-02-06 1979-11-02 Synthelabo Amides d'alkylene-diamines et leur application en therapeutique
JPS5970611A (ja) * 1982-10-15 1984-04-21 Tanabe Seiyaku Co Ltd 医薬組成物

Also Published As

Publication number Publication date
AU574506B2 (en) 1988-07-07
DK160034C (da) 1991-06-17
HU193448B (en) 1987-10-28
CA1256031A (en) 1989-06-20
FR2570275B1 (fr) 1986-11-21
IL76377A (en) 1989-12-15
IL76377A0 (en) 1986-01-31
DK416185D0 (da) 1985-09-13
NZ213465A (en) 1988-06-30
EP0178961A1 (de) 1986-04-23
FR2570275A1 (fr) 1986-03-21
DK416185A (da) 1986-03-15
DE3579098D1 (de) 1990-09-13
EP0178961B1 (de) 1990-08-08
JPS6172718A (ja) 1986-04-14
AU4743085A (en) 1986-04-24
HUT40569A (en) 1987-01-28
DK160034B (da) 1991-01-21

Similar Documents

Publication Publication Date Title
IL74758A0 (en) Acyltripeptides and pharmaceutical compositions containing them
PH22863A (en) Pyrrolobenzimidazoles and pharmaceutical composition containing them
NZ211145A (en) 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
DE3666855D1 (en) Alcalisilicate compositions and their use
IL82221A0 (en) Phenyl-piperazines and pharmaceutical compositions containing them
ZA864602B (en) 2-arylimidazoles and pharmaceutical compositions containing these compounds
NZ212099A (en) Substituted arylhydroxamates and pharmaceutical compositions
NZ216389A (en) Pyrimidines and pharmaceutical compositions
PH21185A (en) 9a-aza-9a-homoerythromycin derivatives and pharmaceutical composition containing them
IL79376A (en) Substituted di-t-butylphenols and pharmaceutical compositions containing them
IL76188A (en) 3-aralkylidene-hydroxy-flavanone derivatives and pharmaceutical compositions containing them
EP0214102A3 (en) 5-aralkyl-substituted 2h-benzotriazoles and stabilized compositions
NZ214821A (en) Spiro-dioxolanes, -dithiolanes and -oxothiolanes and pharmaceutical compositions
NZ215874A (en) Pyrimidines and pharmaceutical compositions
NZ212953A (en) 3-acyl-1-aminoalkyl-1h-indoles and pharmaceutical compositions thereof
GB2167414B (en) Flavolignan derivatives and pharmaceutical compositions containing them
NZ215070A (en) Imidazole-indoles and pharmaceutical compositions
IL79003A0 (en) Tetrahydroimidazoquinazolinones and pharmaceutical compositions containing them
NZ213581A (en) Carboxyalkyldipeptides and pharmaceutical compositions
EP0230052A3 (en) Immunoamplifiers and related compositions
NZ216438A (en) Steroid-pyrazoles and pharmaceutical compositions
IL74667A (en) Spiro-oxazolidones,-thiazolidones and-imidazolidones and pharmaceutical compositions containing them
PH21779A (en) Sulfonomidines and pharmaceutical compositions containing the same
IL79377A0 (en) Substituted di-t-butylphenols and pharmaceutical compositions containing them
IL78918A (en) Spiroheterocyclically-condensed hexahydroaryl-quinolizines and pharmaceutical compositions containing them